# Evaluation of a Screen and Treat Protocol for Influenza

> **NCT06207058** · — · TERMINATED · sponsor: **Tricore, Inc** · enrollment: 25 (actual)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Baloxavir Marboxil

## Key facts

- **NCT ID:** NCT06207058
- **Lead sponsor:** Tricore, Inc
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-01-15
- **Primary completion:** 2024-05-31
- **Final completion:** 2024-07-01
- **Target enrollment:** 25 (ACTUAL)
- **Why stopped:** Limited enrollment opportunities due to low rates of viral infections
- **Last updated:** 2025-05-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06207058

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06207058, "Evaluation of a Screen and Treat Protocol for Influenza". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT06207058. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*